Centres Of Excellence

To focus on new and emerging areas of research and education, Centres of Excellence have been established within the Institute. These ‘virtual' centres draw on resources from its stakeholders, and interact with them to enhance core competencies

Read More >>

Faculty

Faculty members at IIMB generate knowledge through cutting-edge research in all functional areas of management that would benefit public and private sector companies, and government and society in general.

Read More >>

IIMB Management Review

Journal of Indian Institute of Management Bangalore

IIM Bangalore offers Degree-Granting Programmes, a Diploma Programme, Certificate Programmes and Executive Education Programmes and specialised courses in areas such as entrepreneurship and public policy.

Read More >>

About IIMB

The Indian Institute of Management Bangalore (IIMB) believes in building leaders through holistic, transformative and innovative education

Read More >>

Plant Biotechnology in India

Volume 17, Number 4 Article by A Damodaran December, 2005

Plant Biotechnology in India: A Pointer to the Future :

Since the 1990s, India’s biotechnology industry has made rapid progress and is emerging as one of the fastest growing industries, in terms of the volumes of investment attracted. A Damodaran discusses the structural issues connected with the development of the biotechnology industry in India and considers certain critical issues that are likely to inhibit its rapid growth. Intellectual property rights and post R&D regulatory frameworks could be critical factors in promoting investments in the biotech sector. Private investments in the sector are crucially conditioned by differences in IPR regimes.

The multi-layered regulations have their advantages as well as disadvantages. Their emphasis on the elements of biosafety, food security and conservation of biological resources could promote producer and consumer welfare, besides spurring technological innovations. However, in the post R&D phase they create complications, which are expressed in the delays in commercial application of invented products or technologies. The time consuming Bt cotton development and commercialisation process in India is a case in point. The challenge is how to streamline post R&D regulations for biotech products in India, without compromising on bio-safety, sustainability and farmers rights.

The multi-regulatory controls on the post R&D segment of the biotech value chain could prove the critical foundation for strategic alliances between start-up companies and downstream units in India’s biotech sector. The paper suggests various models to enable the process. In the case of transgenics, the regulations are major checkpoints in product development. The problems of pricing and marketing of transgenics are critical, given the vagaries of demand for transgenic plants and seeds in the Indian agriculture sector. The paper rounds off its principal arguments by proposing incorporation of product development concerns in existing national and sub-national biotech policies.

Reprint No 05405